If the PTX-100 interim report see's more responses than 50c-80c is not out of the realms.
Given the 2/2 response rate in the basket cohort.
Any further responses this early into the expanded cohort specifically targeting PTCL/TCL would be even more compelling than responses in your average phase 1B trial.
Given the unmet need, an interim report detailing responses would almost all but guarantee a registrational trial...Investors could start positioning well in advance of the headline readout.
Trading patterns are identical to yesterday, accumulate and drop a small sell order into the dying minutes of trade to try and keep the price artificially low but without offering a parcel worth chomping...They want to hang on and not risk what they have accumulated imo.
PTX Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held
